Dáil Éireann Debate, Wednesday - 11 October 2017
136. Deputy Clare Daly asked the Minister for Health if a meeting will take place between the head of the corporate pharmaceutical unit in the HSE and a company (details supplied) in order to approve kuvan for those with PKU. [43117/17]
View answerUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
